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Background
Previously, we have shown that increased visceral adip-
osity was an independent predictor of thoracic aortic
wall thickness in elderly individuals at risk for future
cardiovascular (CV) events. In this study, we sought to
assess the influence of obesity on rest and stress induced
changes in aortic stiffness in older individuals with
hypertension, diabetes or coronary artery disease at risk
for future CV events.
Methods
We performed dobutamine CMR on 302 consecutively
referred middle aged and older individuals with hyperten-
sion, diabetes, or CAD. We assessed aortic stiffness using
the ratio of pulse pressure to stroke volume index (PP/
SVI). Left ventricular stroke volume was assessed using
cine MRI at rest and with peak stress. All analyses were
performed by individuals blinded to the CMR imaging
procedure and participant identifiers. The group was
divided into tertiles based on BMI (< 27, 27-32, >32)
among 3 age groups (55-64, 65-74, 75+). The correlation
between BMI expressed in tertiles and the resting PP/SVI
and the changes with dobutamine was assessed using lin-
ear regression. This was tested for an interaction with age.
Values are expressed as mean±standard error; p value of
<0.05 was considered significant.
Results
The demographics and results are shown in Figure 1. At
rest there were no differences in the PP/SVI between the
three BMI groups in all age groups. After dobutamine,
subjects aged 55-64 in the highest BMI tertile (> 32) had
an increase in the PP/SVI by 0.115±0.105 similar to that of
subjects aged 75+ in the highest BMI tertile, 0.205±0.168
(Figure 2). In contrast, both both subjects aged 55-64 and
75+ in the low and medium BMI tertiles experienced a
decrease in the PP/SVI with dobutamine, -0.122±0.133
and -0.150±0.086 for the 55-64 age group and -0.290
±0.115 and -0.044±0.089 in the 75+ age group. After
adjusting for age and gender, stress PP/SVI and the change
in PP/SVI had a significant association with BMI (p =0.005
and p< 0.0001) respectively. Age had a significant interac-
tion in this relationship (p = 0.02), whereas fasting glucose
did not have a significant interaction.
1Cardiology, Wake Forest University School of Medicine, Winston-Salem, NC,
USA
Full list of author information is available at the end of the article
Figure 1 Change in PP/SVI: Stress- Rest
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Conclusions
Middle aged and elderly subjects with BMI >32 have
increased aortic stiffness after dobutamine stress in con-
trast to those with BMI <32. The prognostic significance
of the increased aortic stiffness with stress in obese indi-
viduals and its relationship to ventricular remodeling
deserve further study.
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Table 1 Demographics and results
Measure BMI < 27.45 (N=98) BMI 27.45-32 (N=101) BMI > 32 (N=103) p-value with BMI
Age 70.3 (8.0) 68.9 (7.8) 66.6 (8.0) 0.0003
55-64 24 (24.5 %) 35 (34.6%) 48 (46.6%)
65-74 40 (40.8%) 38 (37.6%) 34 (33.0%)
75+ 34 (34.7%) 28 (27.7%) 21 (20.9%)
Female 50 (51.0%) 47 (46.5%) 71 (68.9%) 0.018
Race 0.0017
Caucasian 88 (89.8%) 80 (79.2%) 71 (68.9%)
African Am. 6 (11.1%) 17 (31.5%) 31 (30.1%)
Prior HTN 88 (89.8%) 92 (91.0%) 98 (95.2%) 0.23
Prior DM 0.018
None 64 (65.3%) 60 (59.4%) 55 (53.4%)
< 5 years 34 (34.7%) 33 (32.7%) 40 (38.8%)
= 5 years 0 8 (7.9%) 8 (7.8%)
Prior CAD 27 (27.6%) 22 (21.8%) 16 (15.5%) 0.34
SQ fat 143.1 (56.7) 202.9 (73.7) 325.5 (132.4) < 0.0001
Visceral fat 142.6 (72.6) 197.3 (94.7) 238.4 (97.8) < 0.0001
Taking drugs
ACE 48 (49.0%) 50 (49.5%) 39 (37.9%) 0.27
ARB 4 (4.2%) 4 (4.2%) 3 (2.9%) 0.73
Statin 64 (65.4%) 64 (65.4%) 69 (67.0%) 0.82
Beta blocker 45 (45.9%) 45 (45.9%) 41 (39.8%) 0.43
Ca Ch. BL. 23 (23.5%) 23 (23.5%) 25 (24.5%) 0.67
Rest_55-64 1.618 ± 0.119 1.528 ± 0.096 1.45 ± 0.069
Stress_55-64 1.528 ± 0.107 1.371 ± 0.103 1.513 ± 0.092
Rest_65-74 1.719 ± 0.074 1.63 ± 0.075 1.739 ± 0.089
Stress_65-74 1.537 ± 0.07 1.842 ± 0.102 1.701 ± 0.084
Rest_75+ 1.898 ± 0.08 1.848 ± 0.103 1.79 ± 0.088
Stress_75+ 1.694 ± 0.11 1.784 ± 0.123 1.962 ± 0.152
Vasu et al. Journal of Cardiovascular Magnetic
Resonance 2013, 15(Suppl 1):O45
http://www.jcmr-online.com/content/15/S1/O45
Page 2 of 2
